MDB Capital Holdings (MDBH) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Mar, 2026Executive summary
Focused on scaling the business model of launching public venture companies, aiming to increase from one launch every 18 months to three to five per year, leveraging AI to accelerate due diligence and company preparation processes.
Four principal assets highlighted: eXoZymes, POLX, MDB Direct, and PatentVest, each with significant independent value and billion-dollar market potential.
AI adoption has dramatically reduced time and labor for due diligence, enabling faster company launches and improved operational efficiency.
Strategic investments in MDB Direct (clearing operations) and PatentVest are positioned for spin-out and monetization, with ongoing discussions for partnerships.
Despite challenging market conditions and stock performance, management remains optimistic about future growth and shareholder value creation.
Financial highlights
Year-end cash and current assets, net of liabilities, totaled $22.3 million.
Fixed operating expenses were about $10 million, with a cash burn of $5.7 million for the year; $4 million of this was invested in MDB Direct and PatentVest.
Adjusted for these investments, effective cash burn would have been $1.7 million.
Post-spinout of MDB Direct and PatentVest, operating expenses are expected to drop to $6 million annually, increasing financial leverage.
Outlook and guidance
Positioned to launch 3-5 high-quality companies per year, contingent on solving distribution challenges.
Plans to spin out and monetize MDB Direct and PatentVest, with PatentVest targeted for a public offering in 2027.
Continued focus on expanding distribution and investor base to support increased deal flow.
Latest events from MDB Capital Holdings
- Public venture model delivers liquid, tax-advantaged access to high-growth companies.MDBH
Investor presentation16 Mar 2026 - IPO launches with LTIR, offering downside protection and incentives for long-term investors.MDBH
Status Update15 Jan 2026 - Invizyne IPO, deep tech pipeline, and investor growth drive expansion despite higher losses.MDBH
Q3 202412 Jan 2026 - eXoZymes IPO and deconsolidation clarify results as platform and investor base expand.MDBH
Q4 202426 Dec 2025 - Shareholders will vote on directors and auditor, with control held by Class B shares and strong governance oversight.MDBH
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, auditor ratification, and governance policies.MDBH
Proxy Filing2 Dec 2025 - Q2 2025 net loss rose to $8.25M as focus shifts to profitable IPOs and a PatentVest spin-off.MDBH
Q2 202523 Nov 2025 - Scaling launches and major equity deals position for upside as market recovery is expected.MDBH
Q3 202521 Nov 2025 - Q1 2025 saw strong financings, platform growth, and a volatile portfolio amid macro risks.MDBH
Q1 202512 Nov 2025